-
Market Movers: Alibaba Group Holding Ltd (NYSE:BABA), Dicerna Pharmaceuticals (NASDAQ:DRNA), Gulf Resources (NASDAQ:GURE), Gladstone Land Corporation (NASDAQ:LAND), Salisbury Bancorp (NASDAQ:SAL)
On Friday shares of Alibaba Group Holding Ltd (NYSE:BABA) closed at $88.46. Company’s EPS growth for next 5 years is recorded as 28.75%. Alibaba Group Holding Limited (NYSE:BABA) announced the launch of the Korea Pavilion on Tmall.com, China’s largest third-party B2C platform for brands and retailers. The Korea Pavilion is the first official online country…
-
Best Stocks: Flamel Technologies SA (NASDAQ:FLML), Cellectis S.A. (NASDAQ:CLLS), Oclaro (NASDAQ:OCLR), Salisbury Bancorp Inc. (NASDAQ:SAL), Toyota Motor Corporation (NYSE:TM)
On Friday shares of Flamel Technologies SA (NASDAQ:FLML) closed at $16.27. Company’s sales growth for last 5 years was -18.90% and EPS growth for next 5 years is recorded as 34.00%. Flamel Technologies SA (NASDAQ:FLML) will release financial results for the first quarter of fiscal year 2015 on Friday, May 15, 2015, before the market…
-
Market Movers: Freeport-McMoRan Inc. (NYSE:FCX), Albemarle Corporation (NYSE:ALB), Salisbury Bancorp Inc. (NASDAQ:SAL), Canadian Imperial Bank of Commerce (NYSE:CM), TE Connectivity (NYSE:TEL)
Stock-market analysts have been reducing their expectations for Freeport-McMoRan Inc. (NYSE:FCX) after the Phoenix company reported a $2.9-billion loss in its latest quarter as the firm warned of new cost-cutting and financing needs. The reduced expectations for the mining and energy giant — still Arizona’s most valuable corporation — started about two months ago and…
-
Traders Are Gambling on: Banco Santander, S.A. (NYSE:SAN), Juno Therapeutics Inc. (NASDAQ:JUNO), Gas Natural Inc. (NYSEMKT:EGAS), Signet Jewelers (NYSE:SIG), Salisbury Bancorp (NASDAQ:SAL)
Banco Santander, S.A. (NYSE:SAN) announced it will trade ex-dividend, for its quarterly dividend of $0.4062, payable on 2/2/15. On Wednesday shares of Banco Santander, S.A. (NYSE:SAN) closed at $6.96. Company’s sales growth for last 5 years was -1.30% and EPS growth for next 5 years is recorded as 9.90%. On 6 January Juno Therapeutics Inc.…
-
5 Stock in Different Moves: ARMOUR Residential REIT (NYSE:ARR), Newmont Mining (NYSE:NEM), Franklin Resources (NYSE:BEN), Salisbury Bancorp (NASDAQ:SAL), Great Southern Bancorp (NASDAQ:GSBC)
ARMOUR Residential REIT (NYSE:ARR) announced a monthly dividend on Tuesday, December 23rd. Shareholders of record on Friday, February 13th will be paid a dividend of 0.04 per share on Friday, February 27th. This represents a $0.48 annualized dividend and a dividend yield of 12.97%. The ex-dividend date is Wednesday, February 11th. ARMOUR Residential REIT, Inc.…
-
Notable Ups And Down: Exxon Mobil Corporation (NYSE:XOM), Windstream Holdings (NASDAQ:WIN), CombiMatrix Corporation (NASDAQ:CBMX), Manitex International (NASDAQ:MNTX), Salisbury Bancorp (NASDAQ:SAL)
Exxon Mobil Corporation (NYSE:XOM) VP David S. Rosenthal sold 4,266 shares of the stock in a transaction that occurred on Friday, December 5th. The shares were sold at an average price of $94.00, for a total transaction of $401,004.00. Following the completion of the sale, the vice president now directly owns 144,400 shares of the…
-
Market Movers: NXP Semiconductors NV (NASDAQ:NXPI), Nabors Industries (NYSE:NBR), Cherry Hill Mortgage Investment (NYSE:CHMI), Selective Insurance (NASDAQ:SIGI), Salisbury Bancorp (NASDAQ:SAL)
On 25 November NXP Semiconductors NV (NASDAQ:NXPI) announced the pricing of its previously announced private offering of $1 billion aggregate principal amount of 1.00% cash convertible senior notes due 2019 (the “Notes”) pursuant to Rule 144A and Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”). NXP has granted the…
-
Active Stocks: Ampio Pharmaceuticals (NYSEMKT:AMPE), Glu Mobile (NASDAQ:GLUU), First Horizon National (NYSE:FHN), Salisbury Bancorp (NASDAQ:SAL), Global Brass Holdings (NYSE:BRSS)
Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) today announced an update on the phase III, multicenter, double-blind STEP study of Ampion™ for osteoarthritis of the knee. The STEP study enrolled 538 patients, 269 patients received Ampion™ and 269 patients received saline vehicle control. There were two primary endpoints: 1. Efficacy in reducing pain, as measured by the WOMAC A pain…